[Clinical application of FRAX® in Japan].
FRAX® is a fracture risk assessment tool developed by WHO working groups. Ten-year risks for major osteoporotic fractures or hip fracture can be calculated with FRAX®. It has been discussed how to utilize FRAX® in the clinical settings in Japan. It was necessary to recognize the performance and limitation of this tool. In the Japanese guideline for prevention and treatment of osteoporosis 2011, a threshold of 10-year risk for major osteoporotic risk was proposed for the patients with osteopenia. It is emphasized that this is the proposal to use FRAX® in addition to the result of bone mineral density measurement and is not the proposal to use FRAX® as a screening tool. The way to utilize FRAX® as a screening tool should be investigated further.
Department of Clinical Research and Development, National Center for Geriatrics and Gerontology, Japan.
Takayuki
T
Hosoi
D000367:Age Factors; D015519:Bone Density / Q000502:physiology*; D017408:Guidelines as Topic; D006801:Humans; D007564:Japan; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy; D058866:Osteoporotic Fractures / Q000175:diagnosis*; D018570:Risk Assessment